Effects of Antifungal Agents Alone and in Combination Against Candida glabrata Strains Susceptible or Resistant to Fluconazole
- 22 April 2012
- journal article
- Published by Springer Nature in Mycopathologia
- Vol. 174 (3) , 215-221
Abstract
The rise of Candida spp. resistant to classic triazole antifungal agents has led to a search for new therapeutic options. Here, we evaluated combinations of antifungals in a checkerboard assay against two groups of Candida glabrata strains: one containing fluconazole-susceptible clinical isolates (FS) and another containing fluconazole-resistant laboratory derivative (FR). The most synergistic combination observed was amphotericin B + flucytosine (synergistic for 61.77 % of FS strains and 76.47 % of FR strains). The most antagonistic combination observed was ketoconazole + flucytosine (FS 61.77 % and FR 55.88 %). Surprisingly, most combinations evidenced indifferent interactions, and the best synergism appeared when amphotericin B and flucytosine were combined against both groups of isolates.Keywords
This publication has 29 references indexed in Scilit:
- Successful treatment of prosthetic knee Candida glabrata infection with caspofungin combined with flucytosineInternational Journal of Antimicrobial Agents, 2008
- Epidemiology of Invasive Candidiasis: a Persistent Public Health ProblemClinical Microbiology Reviews, 2007
- Epidemiology of Candidemia in Brazil: a Nationwide Sentinel Surveillance of Candidemia in Eleven Medical CentersJournal of Clinical Microbiology, 2006
- Caspofungin in Combination with Amphotericin B against Candida glabrataAntimicrobial Agents and Chemotherapy, 2005
- Differences in Interactions between Azole Drugs Related to Modifications in the 14-α Sterol Demethylase Gene ( cyp51A ) of Aspergillus fumigatusAntimicrobial Agents and Chemotherapy, 2005
- Synergistic Activities of Fluconazole and Voriconazole with Terbinafine against Four Candida Species Determined by Checkerboard, Time-Kill, and Etest MethodsAntimicrobial Agents and Chemotherapy, 2005
- In Vitro Activities of Voriconazole in Combination with Three Other Antifungal Agents against Candida glabrataAntimicrobial Agents and Chemotherapy, 2004
- In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance programDiagnostic Microbiology and Infectious Disease, 2004
- Combined topical flucytosine and amphotericin B for refractory vaginal Candida glabrata infectionsSexually Transmitted Infections, 2001
- Azole resistance inCandidaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1997